Alzheimer’s drug trial results hailed as ‘revolutionary

Clinical specialists hailed the outcomes of a research of an experimental Alzheimer’s medicine called Lecanemab, which slowed down cognitive decline in a very closely seen test yet may bring a risk of serious side impacts for sure patients.

#News #Reuters #newsfeed #Alzheimers

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the most up to date service, finance as well as breaking news video clip from around the world. Our track record for precision as well as impartiality is unrivaled.

Obtain the most recent news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Adhere To Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en